Functional characterization of the protein C A267T mutation: Evidence for impaired secretion due to defective intracellular transport

BMC Cell Biology

Volumn 11, Issue , 2010, Pages

  Tjeldhorn, Lena ^a,c   Iversen, Nina ^a   Sandvig, Kirsten ^b,c   Bergan, Jonas ^b,c   Sandset, Per M ^a,c   Skretting, Grethe ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BAFILOMYCIN; COMPLEMENTARY DNA; LACTACYSTIN; MESSENGER RNA; N ACETYL BETA GLUCOSAMINIDASE; PROTEASOME; PROTEIN C;

ANIMAL CELL; ARTICLE; CELL LEVEL; CELLULAR DISTRIBUTION; CHO CELL; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; GENE MUTATION; GENETIC ASSOCIATION; GENETIC TRANSFECTION; GOLGI COMPLEX; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LYSOSOME; MOLECULAR WEIGHT; MUTATIONAL ANALYSIS; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN C DEFICIENCY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN SECRETION; PROTEIN STABILITY; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WILD TYPE; ANIMAL; BLOOD CLOTTING; CHROMOSOME DISORDER; CRICETULUS; GENETICS; HAMSTER; METABOLISM; MUTATION; RECURRENT DISEASE; RISK FACTOR; TRANSGENE; VEIN THROMBOSIS;

ANIMALS; BLOOD COAGULATION; CHO CELLS; CHROMOSOME DISORDERS; CRICETINAE; CRICETULUS; HUMANS; MUTATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN C; PROTEIN TRANSPORT; RECURRENCE; RISK FACTORS; TRANSGENES; VENOUS THROMBOSIS;

EID: 77956495529     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-11-67     Document Type: Article

References (42)

1. Dahlback B, Villoutreix BO. Molecular recognition in the protein C anticoagulant pathway. J Thromb Haemost 2003, 1:1525-1534. 10.1046/j.1538-7836.2003.00299.x, 12871288.
2. Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981, 68:1370-1373. 10.1172/JCI110385, 370934, 6895379.
3. Vossen CY, Conard J, Fontcuberta J, Makris M, Van Der Meer FJ, Pabinger I, et al. Familial thrombophilia and lifetime risk of venous thrombosis. J Thromb Haemost 2004, 2:1526-1532. 10.1111/j.1538-7836.2004.00852.x, 15333025.
4. Griffin JH, Fernandez JA, Gale AJ, Mosnier LO. Activated protein C. J Thromb Haemost 2007, 5(Suppl 1):73-80. 10.1111/j.1538-7836.2007.02491.x, 17635713.
5. Grinnell BW, Walls JD, Gerlitz B. Glycosylation of human protein C affects its secretion, processing, functional activities, and activation by thrombin. J Biol Chem 1991, 266:9778-9785.
6. D'Ursi P, Marino F, Caprera A, Milanesi L, Faioni EM, Rovida E. ProCMD: a database and 3 D web resource for protein C mutants. BMC Bioinformatics 2007, 8(Suppl 1):S11. 10.1186/1471-2105-8-S1-S11, 1885840, 17430555.
7. Katsumi A, Senda T, Yamashita Y, Yamazaki T, Hamaguchi M, Kojima T, et al. Protein C Nagoya, an elongated mutant of protein C, is retained within the endoplasmic reticulum and is associated with GRP78 and GRP94. Blood 1996, 87:4164-4175.
8. Lind B, Koefoed P, Thorsen S. Symptomatic type 1 protein C deficiency caused by a de novo Ser270Leu mutation in the catalytic domain. Br J Haematol 2001, 113:642-648. 10.1046/j.1365-2141.2001.02809.x, 11380450.
9. Lind B, Gedde-Dahl T, Tjonnfjord G, Villoutreix BO, Brosstad F. Protein C deficiency caused by homozygosity for a novel PROC D180G mutation--in vitro expression and structural analysis of the mutation. Thromb Haemost 2002, 88:632-638.
10. Naito M, Mimuro J, Endo H, Madoiwa S, Ogata K, Kikuchi J, et al. Defective sorting to secretory vesicles in trans-Golgi network is partly responsible for protein C deficiency: molecular mechanisms of impaired secretion of abnormal protein C R169W, R352W, and G376D. Circ Res 2003, 92:865-872. 10.1161/01.RES.0000069020.87627.7D, 12663483.
11. Sugahara Y, Miura O, Yuen P, Aoki N. Protein C deficiency Hong Kong 1 and 2:hereditary protein C deficiency caused by two mutant alleles, a 5-nucleotide deletion and a missense mutation. Blood 1992, 80:126-133.
12. Sugahara Y, Miura O, Hirosawa S, Aoki N. Compound heterozygous protein C deficiency caused by two mutations, Arg-178 to Gln and Cys-331 to Arg, leading to impaired secretion of mutant protein C. Thromb Haemost 1994, 72:814-818.
13. Tokunaga F, Tsukamoto T, Koide T. Cellular basis for protein C deficiency caused by a single amino acid substitution at Arg15 in the gamma-carboxyglutamic acid domain. J Biochem 1996, 120:360-368.
14. Yamamoto K, Matsushita T, Sugiura I, Takamatsu J, Iwasaki E, Wada H, et al. Homozygous protein C deficiency: identification of a novel missense mutation that causes impaired secretion of the mutant protein C. J Lab Clin Med 1992, 119:682-689.
15. Zhou RF, Cai XH, Xie S, Wang XF, Wang HL. Molecular mechanism for hereditary protein C deficiency in two Chinese families with thrombosis. J Thromb Haemost 2006, 4:1154-1156. 10.1111/j.1538-7836.2006.01913.x, 16689777.
16. Malhotra JD, Kaufman RJ. The endoplasmic reticulum and the unfolded protein response. Semin Cell Dev Biol 2007, 18:716-731. 10.1016/j.semcdb.2007.09.003, 2706143, 18023214.
17. Trombetta ES, Parodi AJ. Quality control and protein folding in the secretory pathway. Annu Rev Cell Dev Biol 2003, 19:649-676. 10.1146/annurev.cellbio.19.110701.153949, 14570585.
18. Hebert DN, Molinari M. In and out of the ER: protein folding, quality control, degradation, and related human diseases. Physiol Rev 2007, 87:1377-1408. 10.1152/physrev.00050.2006, 17928587.
19. Lee SA, Belyaeva OV, Kedishvili NY. Disease-associated variants of microsomal retinol dehydrogenase 12 (RDH12) are degraded at mutant-specific rates. FEBS Lett 2010, 584:507-510. 10.1016/j.febslet.2009.12.009, 20006610.
20. Nishio M, Koyama T, Nakahara M, Egawa N, Hirosawa S. Proteasome degradation of protein C and plasmin inhibitor mutants. Thromb Haemost 2008, 100:405-412.
21. Suzuki K, Murai K, Suwabe A, Ishida Y. Factor XII Ofunato: Lys346Asn mutation associated with blood coagulation factor XII deficiency causes impaired secretion through a proteasome-mediated degradation. Thromb Res 2010, 125:438-443. 10.1016/j.thromres.2009.12.004, 20022356.
22. Tokunaga F, Shirotani H, Hara K, Kozuki D, Omura S, Koide T. Intracellular degradation of secretion defect-type mutants of antithrombin is inhibited by proteasomal inhibitors. FEBS Lett 1997, 412:65-69. 10.1016/S0014-5793(97)00745-X, 9257691.
23. Schroder M, Kaufman RJ. ER stress and the unfolded protein response. Mutat Res 2005, 569:29-63.
24. Menendez-Benito V, Verhoef LG, Masucci MG, Dantuma NP. Endoplasmic reticulum stress compromises the ubiquitin-proteasome system. Hum Mol Genet 2005, 14:2787-2799. 10.1093/hmg/ddi312, 16103128.
25. Uchio N, Oma Y, Toriumi K, Sasagawa N, Tanida I, Fujita E, et al. Endoplasmic reticulum stress caused by aggregate-prone proteins containing homopolymeric amino acids. FEBS J 2007, 274:5619-5627. 10.1111/j.1742-4658.2007.06085.x, 17922840.
26. Mancini R, Aebi M, Helenius A. Multiple endoplasmic reticulum-associated pathways degrade mutant yeast carboxypeptidase Y in mammalian cells. J Biol Chem 2003, 278:46895-46905. 10.1074/jbc.M302979200, 12954632.
27. Molinari M. N-glycan structure dictates extension of protein folding or onset of disposal. Nat Chem Biol 2007, 3:313-320. 10.1038/nchembio880, 17510649.
28. Nakahara M, Koyama T, Nakazawa F, Nishio M, Shibamiya A, Hirosawa S. Gradually glycosylated protein C mutants (Arg178Gln and Cys331Arg) are degraded by proteasome after mannose trimming. Thromb Haemost 2004, 92:1284-1290.
29. Tjeldhorn L, Sandset PM, Haugbro K, Skretting G. Hereditary protein C deficiency caused by the Ala267Thr mutation in the protein C gene is associated with symptomatic and asymptomatic venous thrombosis. Thromb Res 2010, 125:230-234. 10.1016/j.thromres.2009.05.013, 19535131.
30. Bross P, Corydon TJ, Andresen BS, Jorgensen MM, Bolund L, Gregersen N. Protein misfolding and degradation in genetic diseases. Hum Mutat 1999, 14:186-198. 10.1002/(SICI)1098-1004(1999)14:3<186::AID-HUMU2>3.0.CO;2-J, 10477427.
31. Ellgaard L, Helenius A. ER quality control: towards an understanding at the molecular level. Curr Opin Cell Biol 2001, 13:431-437. 10.1016/S0955-0674(00)00233-7, 11454449.
32. Enjolras N, Plantier JL, Rodriguez MH, Rea M, Attali O, Vinciguerra C, et al. Two novel mutations in EGF-like domains of human factor IX dramatically impair intracellular processing and secretion. J Thromb Haemost 2004, 2:1143-1154. 10.1111/j.1538-7836.2004.00756.x, 15219198.
33. Arbini AA, Mannucci M, Bauer KA. A Thr359Met mutation in factor VII of a patient with a hereditary deficiency causes defective secretion of the molecule. Blood 1996, 87:5085-5094.
34. Shenkman M, Tolchinsky S, Kondratyev M, Lederkremer GZ. Transient arrest in proteasomal degradation during inhibition of translation in the unfolded protein response. Biochem J 2007, 404:509-516. 10.1042/BJ20061854, 1896287, 17338678.
35. Tanaka Y, Ueda K, Ozawa T, Sakuragawa N, Yokota S, Sato R, et al. Intracellular accumulation of antithrombin Morioka (C95R), a novel mutation causing type I antithrombin deficiency. J Biol Chem 2002, 277:51058-51067. 10.1074/jbc.M210231200, 12399451.
36. Nishitsuji K, Tomiyama T, Ishibashi K, Ito K, Teraoka R, Lambert MP, et al. The E693Delta mutation in amyloid precursor protein increases intracellular accumulation of amyloid beta oligomers and causes endoplasmic reticulum stress-induced apoptosis in cultured cells. Am J Pathol 2009, 174:957-969. 10.2353/ajpath.2009.080480, 2665755, 19164507.
37. Donoso G, Herzog V, Schmitz A. Misfolded BiP is degraded by a proteasome-independent endoplasmic-reticulum-associated degradation pathway. Biochem J 2005, 387:897-903. 10.1042/BJ20041312, 1135023, 15610068.
38. Fayadat L, Siffroi-Fernandez S, Lanet J, Franc JL. Degradation of human thyroperoxidase in the endoplasmic reticulum involves two different pathways depending on the folding state of the protein. J Biol Chem 2000, 275:15948-15954. 10.1074/jbc.M905763199, 10748076.
39. Wakabayashi S, Yoshida H, Shigekiyo T, Koide T. Intracellular degradation of histidine-rich glycoprotein mutants: tokushima-1 and 2 mutants are degraded by different proteolytic systems. J Biochem 2000, 128:201-206.
40. Ciechanover A, Schwartz AL. The ubiquitin system: pathogenesis of human diseases and drug targeting. Biochim Biophys Acta 2004, 1695:3-17. 10.1016/j.bbamcr.2004.09.018, 15571805.
41. McClure DB, Walls JD, Grinnell BW. Post-translational processing events in the secretion pathway of human protein C, a complex vitamin K-dependent antithrombotic factor. J Biol Chem 1992, 267:19710-19717.
42. Hansson K, Stenflo J. Post-translational modifications in proteins involved in blood coagulation. J Thromb Haemost 2005, 3:2633-2648. 10.1111/j.1538-7836.2005.01478.x, 16129023.